Literature DB >> 29782018

Novel Method of Plasmid DNA Delivery to Mouse Bladder Urothelium by Electroporation.

Chuan Yu1, Ofir Stefanson1, Yueli Liu1, Zhu A Wang2.   

Abstract

Genetically engineered mouse models (GEMMs) are extremely valuable in revealing novel biological insights into the initiation and progression mechanisms of human diseases such as cancer. Transgenic and conditional knockout mice have been frequently used for gene overexpression or ablation in specific tissues or cell types in vivo. However, generating germline mouse models can be time-consuming and costly. Recent advancements in gene editing technologies and the feasibility of delivering DNA plasmids by viral infection have enabled rapid generation of non-germline autochthonous mouse cancer models for several organs. The bladder is an organ that has been difficult for viral vectors to access, due to the presence of a glycosaminoglycan layer covering the urothelium. Here, we describe a novel method developed in lab for efficient delivery of DNA plasmids into the mouse bladder urothelium in vivo. Through intravesical instillation of pCAG-GFP DNA plasmid and electroporation of surgically exposed bladder, we show that the DNA plasmid can be delivered specifically into the bladder urothelial cells for transient expression. Our method provides a fast and convenient way for overexpression and knockdown of genes in the mouse bladder, and can be applied to building GEMMs of bladder cancer and other urological diseases.

Entities:  

Mesh:

Year:  2018        PMID: 29782018      PMCID: PMC6101102          DOI: 10.3791/57649

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  22 in total

Review 1.  Electroporation-based technologies for medicine: principles, applications, and challenges.

Authors:  Martin L Yarmush; Alexander Golberg; Gregor Serša; Tadej Kotnik; Damijan Miklavčič
Journal:  Annu Rev Biomed Eng       Date:  2014-05-27       Impact factor: 9.590

Review 2.  The mighty mouse: genetically engineered mouse models in cancer drug development.

Authors:  Norman E Sharpless; Ronald A Depinho
Journal:  Nat Rev Drug Discov       Date:  2006-08-18       Impact factor: 84.694

3.  Efficient gene transfer into the embryonic mouse brain using in vivo electroporation.

Authors:  T Saito; N Nakatsuji
Journal:  Dev Biol       Date:  2001-12-01       Impact factor: 3.582

4.  Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer.

Authors:  Motoyuki Yamashita; Charles J Rosser; Jain-Hua Zhou; Xin-Qiao Zhang; Robert J Connor; Heidrun Engler; Daniel C Maneval; Takashi Karashima; Bogdan A Czerniak; Colin P N Dinney; William F Benedict
Journal:  Cancer Gene Ther       Date:  2002-08       Impact factor: 5.987

5.  Electroporation and RNA interference in the rodent retina in vivo and in vitro.

Authors:  Takahiko Matsuda; Constance L Cepko
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-05       Impact factor: 11.205

Review 6.  Immune responses to lentiviral vectors.

Authors:  Antonia Follenzi; Laura Santambrogio; Andrea Annoni
Journal:  Curr Gene Ther       Date:  2007-10       Impact factor: 4.391

7.  Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.

Authors:  Hao Yin; Wen Xue; Sidi Chen; Roman L Bogorad; Eric Benedetti; Markus Grompe; Victor Koteliansky; Phillip A Sharp; Tyler Jacks; Daniel G Anderson
Journal:  Nat Biotechnol       Date:  2014-03-30       Impact factor: 54.908

8.  Efficient in vivo electroporation of the postnatal rodent forebrain.

Authors:  Camille Boutin; Simone Diestel; Angélique Desoeuvre; Marie-Catherine Tiveron; Harold Cremer
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

9.  A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice.

Authors:  Yang Yang; Lili Wang; Peter Bell; Deirdre McMenamin; Zhenning He; John White; Hongwei Yu; Chenyu Xu; Hiroki Morizono; Kiran Musunuru; Mark L Batshaw; James M Wilson
Journal:  Nat Biotechnol       Date:  2016-02-01       Impact factor: 54.908

10.  Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis.

Authors:  Rodrigo Romero; Volkan I Sayin; Shawn M Davidson; Matthew R Bauer; Simranjit X Singh; Sarah E LeBoeuf; Triantafyllia R Karakousi; Donald C Ellis; Arjun Bhutkar; Francisco J Sánchez-Rivera; Lakshmipriya Subbaraj; Britney Martinez; Roderick T Bronson; Justin R Prigge; Edward E Schmidt; Craig J Thomas; Chandra Goparaju; Angela Davies; Igor Dolgalev; Adriana Heguy; Viola Allaj; John T Poirier; Andre L Moreira; Charles M Rudin; Harvey I Pass; Matthew G Vander Heiden; Tyler Jacks; Thales Papagiannakopoulos
Journal:  Nat Med       Date:  2017-10-02       Impact factor: 53.440

View more
  1 in total

Review 1.  piggyBac-Based Non-Viral In Vivo Gene Delivery Useful for Production of Genetically Modified Animals and Organs.

Authors:  Masahiro Sato; Emi Inada; Issei Saitoh; Satoshi Watanabe; Shingo Nakamura
Journal:  Pharmaceutics       Date:  2020-03-19       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.